Estimated Clinical Trial Capacity of Sites Participating in the COVID-19 Convalescent Plasma Expanded Access Program

This cross-sectional study estimates the trial capacity of sites participating in the COVID-19 convalescent plasma expanded access program.

Detalles Bibliográficos
Autores principales: Gustafson, M. Sage, Patel, Aman, Hong, Chuan, Meline, Miles, Peña, Daniella, Tang, Charis, Fernandez Lynch, Holly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582895/
https://www.ncbi.nlm.nih.gov/pubmed/36260335
http://dx.doi.org/10.1001/jamanetworkopen.2022.37540
_version_ 1784812947761004544
author Gustafson, M. Sage
Patel, Aman
Hong, Chuan
Meline, Miles
Peña, Daniella
Tang, Charis
Fernandez Lynch, Holly
author_facet Gustafson, M. Sage
Patel, Aman
Hong, Chuan
Meline, Miles
Peña, Daniella
Tang, Charis
Fernandez Lynch, Holly
author_sort Gustafson, M. Sage
collection PubMed
description This cross-sectional study estimates the trial capacity of sites participating in the COVID-19 convalescent plasma expanded access program.
format Online
Article
Text
id pubmed-9582895
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-95828952022-11-04 Estimated Clinical Trial Capacity of Sites Participating in the COVID-19 Convalescent Plasma Expanded Access Program Gustafson, M. Sage Patel, Aman Hong, Chuan Meline, Miles Peña, Daniella Tang, Charis Fernandez Lynch, Holly JAMA Netw Open Research Letter This cross-sectional study estimates the trial capacity of sites participating in the COVID-19 convalescent plasma expanded access program. American Medical Association 2022-10-19 /pmc/articles/PMC9582895/ /pubmed/36260335 http://dx.doi.org/10.1001/jamanetworkopen.2022.37540 Text en Copyright 2022 Gustafson MS et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Gustafson, M. Sage
Patel, Aman
Hong, Chuan
Meline, Miles
Peña, Daniella
Tang, Charis
Fernandez Lynch, Holly
Estimated Clinical Trial Capacity of Sites Participating in the COVID-19 Convalescent Plasma Expanded Access Program
title Estimated Clinical Trial Capacity of Sites Participating in the COVID-19 Convalescent Plasma Expanded Access Program
title_full Estimated Clinical Trial Capacity of Sites Participating in the COVID-19 Convalescent Plasma Expanded Access Program
title_fullStr Estimated Clinical Trial Capacity of Sites Participating in the COVID-19 Convalescent Plasma Expanded Access Program
title_full_unstemmed Estimated Clinical Trial Capacity of Sites Participating in the COVID-19 Convalescent Plasma Expanded Access Program
title_short Estimated Clinical Trial Capacity of Sites Participating in the COVID-19 Convalescent Plasma Expanded Access Program
title_sort estimated clinical trial capacity of sites participating in the covid-19 convalescent plasma expanded access program
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582895/
https://www.ncbi.nlm.nih.gov/pubmed/36260335
http://dx.doi.org/10.1001/jamanetworkopen.2022.37540
work_keys_str_mv AT gustafsonmsage estimatedclinicaltrialcapacityofsitesparticipatinginthecovid19convalescentplasmaexpandedaccessprogram
AT patelaman estimatedclinicaltrialcapacityofsitesparticipatinginthecovid19convalescentplasmaexpandedaccessprogram
AT hongchuan estimatedclinicaltrialcapacityofsitesparticipatinginthecovid19convalescentplasmaexpandedaccessprogram
AT melinemiles estimatedclinicaltrialcapacityofsitesparticipatinginthecovid19convalescentplasmaexpandedaccessprogram
AT penadaniella estimatedclinicaltrialcapacityofsitesparticipatinginthecovid19convalescentplasmaexpandedaccessprogram
AT tangcharis estimatedclinicaltrialcapacityofsitesparticipatinginthecovid19convalescentplasmaexpandedaccessprogram
AT fernandezlynchholly estimatedclinicaltrialcapacityofsitesparticipatinginthecovid19convalescentplasmaexpandedaccessprogram

Ejemplares similares